Atritech
TriMed Staff | March 24, 2009 | Cardiovascular Business | Patient Care
Atritech (Booth 2857) is highlighting its Watchman left atrial appendage (LAA) system, designed to keep blood clots that form in the LAA from entering the blood stream, potentially causing stroke or other complications. The Watchman system is made of nitinol with the atrial facing surface covered with a thin permeable polyester material. The device is constrained within a catheter until delivery in the LAA and is available in varying sizes. The Watchman currently has FDA approval as an investigational device.

TriMed Staff

Related Content

Cardiologist moves to Mississippi to fight back against PAD and limit amputations
On-pump vs. off-pump CABG: No difference in long-term mortality, meta-analysis confirms
Peripheral artery disease is out of control in many rural, low income communities
The many benefits of using low-cost CT coronary calcium scoring to screen patients
Early feasibility study for implantable heart failure monitor moves forward 
Using 'magic' to calm pediatric patients during imaging exams

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup